Clinical Trials Directory

Trials / Completed

CompletedNCT07506447

The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

Status
Completed
Phase
Study type
Observational
Enrollment
68 (actual)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This project will target patients with histopathologically diagnosed mucosal melanoma using \[¹⁸F\]FDG PET/CT imaging for retrospective prognostic evaluation.The primary objective is to explore the value of \[¹⁸F\]FDG PET/CT imaging in the prognostic assessment of mucosal melanoma, and to determine the correlations between quantitative \[¹⁸F\]FDG PET parameters and progression-free survival (PFS) as well as overall survival (OS), so as to provide reference evidence for individualized treatment decision-making.

Conditions

Interventions

TypeNameDescription
OTHERTelephone follow-upTelephone follow-up

Timeline

Start date
2021-01-01
Primary completion
2025-05-08
Completion
2026-03-13
First posted
2026-04-01
Last updated
2026-04-01

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07506447. Inclusion in this directory is not an endorsement.

The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma (NCT07506447) · Clinical Trials Directory